NOF Corporation - DDS Development

NOF offers innovative excipients in pharmaceuticals such as activated PEGs for drug modification (PEGylation), phospholipid, ultra pure oleic acid, ultra-pure polysorbate 80, ultra-pure PEG 200, 300 and 400, noble solubilization kits, cholesterol pullulan and chitosan. As a worldwide leader in drug delivery systems, NOF provides these excellent quality products for pharmaceutical applications.

Activity:

- Manufacturing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Drug delivery
- Reagents
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter: Japan

b. Continent(s) active: North America , Europe , Asia

c. Countries active: North America, Europe, Asia

Corporate data:

Number of Employees: 1588

Turnover:

Amount:	Year:	Currency:
17,742million	2006	Yen

Year founded: 1937